Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 
5635(c)(4)

Pliant Therapeutics grants 120000 stock options to new SVP of Medical Affairs, Dr. Gary Palmer. Learn about the vesting schedule,...
1 day ago
from: Stock Titan

Continue reading...
Medicine, Nasdaq
More about this
- Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September...
from: Bakersfield.com
- Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant. SOUTH SAN FRANCISCO, Calif., Oct. 01,...
from: The Manila Times
- Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September...
from: WATE 6 On Your Side